As your trusted resource in women’s health diagnostics testing, Quest is committed to fast action on emerging health threats for which laboratory testing can provide critical insights to aid in response. Due to the rapidly shifting nature of the COVID-19 pandemic, please reference our COVID-19 website.
Use the links above to access the latest guidance and news within each topic.
Use the links below to access the latest guidance and news within each topic.
The American College of Obstetricians and Gynecologists (ACOG) is closely monitoring the COVID-19 pandemic and issued a comprehensive practice advisory with updated guidance for managing and evaluating patients. The Practice Advisory includes recently released interim clinical guidance from the Centers for Disease Control (CDC) for management of patients with confirmed COVID-19 infection and guidance for evaluating and reporting persons under investigation (PUI) and reporting suspected or confirmed cases.
The ASCCP has issued interim guidance for timing of diagnostic and treatment procedures for patients with abnormal cervical screening tests.
ACOG and the Society for Maternal-Fetal Medicine (SMFM) have developed an algorithm to aid practitioners in assessing and managing pregnant women with suspected or confirmed COVID-19.
Centers for Disease Control and Prevention (CDC) have provided infection prevention and control considerations for healthcare facilities providing obstetric care for pregnant patients with confirmed coronavirus disease (COVID-19) or pregnant persons under investigation (PUI) in inpatient obstetric healthcare settings including obstetrical triage, labor and delivery, recovery, and inpatient postpartum settings.
American Journal of Obstetrics & Gynecology published an article on COVID-19 and pregnancy.
The American Society for Reproductive Medicine (ASRM) has provided additional guidance in response to the coronavirus (COVID-19) global pandemic. This guidance provides key recommendations around fertility treatment cycles, embryo transfers, elective surgeries, and continued care and management of patients.
The 3 major professional societies leading infertility and reproductive medicine today issued a joint statement on providing infertility care during the ongoing COVID-19 pandemic. Working together, the ASRM, the International Federation of Fertility Societies (IFFS), and the European Society for Human Reproduction and Embryology (ESHRE) developed the guidance document entitled COVID-19 and Human Reproduction.
Our new Peace of Mind program offers exclusive VIP treatment during the first hour of operations for our most vulnerable patients. The program is aimed at patients who are at increased risk for COVID-19, including those who are immunocompromised, pregnant, have underlying health issues, or are 60 years of age or older.
When in-office testing is not an option, your local Quest Diagnostics PSCs can provide the testing that you and your at-risk patients need.